PH13858A - Stabilized thymosin fraction 5 and method for preparing same - Google Patents
Stabilized thymosin fraction 5 and method for preparing sameInfo
- Publication number
- PH13858A PH13858A PH20803A PH20803A PH13858A PH 13858 A PH13858 A PH 13858A PH 20803 A PH20803 A PH 20803A PH 20803 A PH20803 A PH 20803A PH 13858 A PH13858 A PH 13858A
- Authority
- PH
- Philippines
- Prior art keywords
- thymosin fraction
- preparing same
- stabilized
- reconstitution
- permeate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/770,480 US4082737A (en) | 1977-02-22 | 1977-02-22 | Stabilized thymosin composition and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH13858A true PH13858A (en) | 1980-10-22 |
Family
ID=25088687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH20803A PH13858A (en) | 1977-02-22 | 1978-02-21 | Stabilized thymosin fraction 5 and method for preparing same |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4082737A (es) |
| JP (1) | JPS53104719A (es) |
| AT (1) | AT363177B (es) |
| AU (1) | AU516946B2 (es) |
| BE (1) | BE864139A (es) |
| CA (1) | CA1099633A (es) |
| CH (1) | CH632164A5 (es) |
| DE (1) | DE2807202C2 (es) |
| DK (1) | DK78378A (es) |
| FR (1) | FR2380782A1 (es) |
| GB (1) | GB1546027A (es) |
| IE (1) | IE46409B1 (es) |
| IL (1) | IL54063A0 (es) |
| IT (1) | IT1092337B (es) |
| LU (1) | LU79090A1 (es) |
| NL (1) | NL189281C (es) |
| NZ (1) | NZ186489A (es) |
| PH (1) | PH13858A (es) |
| SE (1) | SE444647B (es) |
| ZA (1) | ZA78890B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732587A1 (de) * | 1976-09-22 | 1978-03-23 | Bach Jean Francois | Polypeptid mit thymischer wirksamkeit |
| US4148788A (en) * | 1978-01-23 | 1979-04-10 | Hoffmann-La Roche Inc. | Synthesis of thymosin α1 |
| US4239498A (en) * | 1978-11-27 | 1980-12-16 | Rule Allyn H | Method of preparing thymic factors and composition |
| US4264571A (en) * | 1979-01-22 | 1981-04-28 | George Washington University | Radioimmunoassay of thymosin α1 |
| EP0057702A1 (en) * | 1980-08-08 | 1982-08-18 | Rak-A-Van Pty Limited | Improved racking |
| US4389343A (en) * | 1981-12-24 | 1983-06-21 | Hoffmann-La Roche Inc. | Immunopotentiating peptides from thymus |
| US4388234A (en) * | 1981-12-28 | 1983-06-14 | Hoffmann-La Roche Inc. | Peptide isolation |
| US4614731A (en) * | 1983-09-15 | 1986-09-30 | Hoffmann-La Roche Inc. | Peptide having immunopotentiating activity similar to thymosin alpha1 |
| US4659694A (en) * | 1983-10-27 | 1987-04-21 | Hoffmann-La Roche Inc. | Prothymosin alpha |
| US4814434A (en) * | 1984-02-03 | 1989-03-21 | Ventres Laboratories, Inc. | Inducer of T-suppressor cells |
| DE3633651A1 (de) * | 1986-10-03 | 1988-04-14 | Alfred Dr Dick | Verwendung von fraktionen aus thymus- und milzextrakten zur behandlung der psoriasis |
| US5273963A (en) * | 1991-03-29 | 1993-12-28 | The George Washington University | Compositions and methods for treating small cell and nonsmall cell lung cancers |
| JP4404866B2 (ja) | 2006-03-03 | 2010-01-27 | ゼライス株式会社 | エンドトキシン含有量を低減したゼラチンの製造方法および低エンドトキシンゼラチン |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4002602A (en) * | 1974-03-11 | 1977-01-11 | Gideon Goldstein | Ubiquitous immunopoietic polypeptide (UBIP) and methods |
| US4010148A (en) * | 1975-05-12 | 1977-03-01 | Board Of Regents Of The University Of Texas System | Purified thymosin and process |
| US4002740A (en) * | 1975-08-21 | 1977-01-11 | Gideon Goldstein | Tridecapeptide compositions and methods |
-
1977
- 1977-02-22 US US05/770,480 patent/US4082737A/en not_active Expired - Lifetime
-
1978
- 1978-01-18 CH CH51178A patent/CH632164A5/de not_active IP Right Cessation
- 1978-01-30 IT IT19791/78A patent/IT1092337B/it active
- 1978-02-06 CA CA296,326A patent/CA1099633A/en not_active Expired
- 1978-02-07 NL NLAANVRAGE7801422,A patent/NL189281C/xx not_active IP Right Cessation
- 1978-02-15 NZ NZ186489A patent/NZ186489A/xx unknown
- 1978-02-15 ZA ZA00780890A patent/ZA78890B/xx unknown
- 1978-02-16 IL IL54063A patent/IL54063A0/xx not_active IP Right Cessation
- 1978-02-16 IE IE335/78A patent/IE46409B1/en not_active IP Right Cessation
- 1978-02-16 AU AU33343/78A patent/AU516946B2/en not_active Expired
- 1978-02-20 JP JP1774678A patent/JPS53104719A/ja active Granted
- 1978-02-20 LU LU79090A patent/LU79090A1/xx unknown
- 1978-02-20 DE DE2807202A patent/DE2807202C2/de not_active Expired
- 1978-02-20 FR FR7804718A patent/FR2380782A1/fr active Granted
- 1978-02-21 DK DK78378A patent/DK78378A/da unknown
- 1978-02-21 SE SE7802014A patent/SE444647B/sv unknown
- 1978-02-21 GB GB6845/78A patent/GB1546027A/en not_active Expired
- 1978-02-21 AT AT0124578A patent/AT363177B/de not_active IP Right Cessation
- 1978-02-21 BE BE185321A patent/BE864139A/xx not_active IP Right Cessation
- 1978-02-21 PH PH20803A patent/PH13858A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7801422A (nl) | 1978-08-24 |
| US4082737A (en) | 1978-04-04 |
| JPS53104719A (en) | 1978-09-12 |
| NZ186489A (en) | 1981-01-23 |
| AU516946B2 (en) | 1981-07-02 |
| CA1099633A (en) | 1981-04-21 |
| DE2807202C2 (de) | 1987-04-02 |
| FR2380782A1 (fr) | 1978-09-15 |
| FR2380782B1 (es) | 1980-01-18 |
| LU79090A1 (fr) | 1979-05-25 |
| SE7802014L (sv) | 1978-08-23 |
| AU3334378A (en) | 1979-08-23 |
| GB1546027A (en) | 1979-05-16 |
| ATA124578A (de) | 1980-12-15 |
| CH632164A5 (de) | 1982-09-30 |
| NL189281C (nl) | 1993-03-01 |
| AT363177B (de) | 1981-07-10 |
| ZA78890B (en) | 1979-01-31 |
| IL54063A0 (en) | 1978-04-30 |
| IT1092337B (it) | 1985-07-06 |
| NL189281B (nl) | 1992-10-01 |
| DK78378A (da) | 1978-08-23 |
| IE46409B1 (en) | 1983-06-01 |
| IT7819791A0 (it) | 1978-01-30 |
| SE444647B (sv) | 1986-04-28 |
| JPS618806B2 (es) | 1986-03-18 |
| IE780335L (en) | 1978-08-22 |
| DE2807202A1 (de) | 1978-08-24 |
| BE864139A (fr) | 1978-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2380782B1 (es) | ||
| DK183386A (da) | Sucralfatsuspension | |
| SE8402560L (sv) | Farmaceutisk komposition | |
| IT8026587A0 (it) | Eteri basici, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono. | |
| IT8422580A0 (it) | Composizioni che le contengono e proteine di membrana cellulare, procedimento per prepararle. | |
| MX6015E (es) | Procedimiento para la preparacion de composiciones de globulina de suero inmune,altamente estabilizada | |
| AR240450A1 (es) | Excluida su aplicacion en o sobre animales, derivados de acido oxamidico, procedimiento para su preparacion y composiciones parasiticidas que los contienen. | |
| IT8719389A0 (it) | Impiego di derivati delmetilendiossibenzene con funzione sinergizzante in composizioini per uso insetticida. | |
| IT8548348A0 (it) | Derivati di amminofenolo,procedimento per prepararli e composizione farmaceutica che li contiene | |
| IT1148435B (it) | Perfezionamento nei pannolini monouso per neonati,dotati di nastri di applicazione elasticizzati | |
| MX9207605A (es) | Composicion farmaceutica que contiene glucosidos de antraciclina unidos a un derivado polimerico y metodo para preparar la misma. | |
| SE413171B (sv) | Fergkompositioner for keratinfibrer, i synnerhet for menniskohar, innehallande 3-halogen-6-acetylamino (eller ureido) fenol-kopplingssubstanser | |
| ES505028A0 (es) | Sistema indicador perfeccionado para determinar el periodo de utilidad de productos, con liberacion de agentes activos en la atmosfera. | |
| IT1170749B (it) | Perfezionamento nei sistemi di infusione per uso medicale | |
| IT1168389B (it) | Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono | |
| IT7927018A0 (it) | Procedimento per la preparazione di omega-lattami, in particolare caprolattame. | |
| IT8421310A0 (it) | Meccanismo per mobili per sedersi e, rispettivamente per riposarsi. | |
| FI882887A0 (fi) | Foer klaeder avsedd tvaett- och/eller torkmaskin, vars trumma staengs med regel. | |
| IT8548819A0 (it) | Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli | |
| NO830234L (no) | Daunorubicin- og doxorubicinanaloger, deres fremstilling og bruk. | |
| IT8022188A0 (it) | Derivati nicotinici di glucosamina, procedimento per la preparazione e relative composizioni farmaceutiche. | |
| Bailey-Cristall | Mapleridge: social atmosphere for troubled children | |
| NO913502D0 (no) | Kompositt for anvendelse som hoeyenergi-sprengstoff eller drivmiddel. | |
| IT8323462A0 (it) | Sale di s-adenosil-l-metionina, composizione contenente tale sale preferibilmente per uso farmaceutico e procedimento di preparazione. | |
| FA et al. | Influence of combined effects of bleomycin and X-rays on the growth rate of eat and hela cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Record of annual fee payments |
Year of fee payment: 14 |